Indication
Dermatosis Papulosa Nigra
1 clinical trial
1 product
Product
SM-020Clinical trial
Open-Label Study of the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa NigraStatus: Active (not recruiting), Estimated PCD: 2024-07-25